Updated Thoughts on Social Consumption Lounges: Summer 2023

I was pretty excited about social consumption lounges. These businesses, if located in one of the East Coast markets, are within our investment criteria. I’m sure it will come as no surprise that we have yet to make an investment. More recently, I'm starting to challenge the viability of the stand-alone social consumption lounge idea purely from a consumer experience perspective.

The premise behind separate, stand-alone cannabis social consumption lounges is flawed. It still may work, but it remains somewhat flawed. I think there are some scenarios that still make sense such as a social consumption lounges adjacent or within a cannabis retail environment. Listening to a recent episode of Coffee with the Collective podcast by The Cannabis Collective with Ariel Palitz, New York City´s first “Nightlife Mayor”, she reinforced and validated this thought process for me. During the show, Ariel was answering a question about the challenges of siloing cannabis in the night life scene. She said that it’s challenging because “cannabis is consumed everywhere”. She’s right. Cannabis is used in a wide array of social gathering places and separating that social use from other social gathering places such as bars, restaurants, night clubs and event spaces doesn’t make much sense.

State liquor licensing outfits think they have alcohol and cannabis siloed but they don’t. Finish your drink at the bar, walk outside, smoke a joint, walk right back into the bar and order another drink. Bring an edible with you to the bar and eat it right after your first drink and a few wings.

Cannabis use in social settings will have to become more nuanced for the type of environment the social use is taking place. For example, beer and wine are served and sold in many places where whiskey is not…and for good reason. Allowing different types of cannabis social consumption in different types of social environments needs to be considered and defined. Cannabis beverages at a bar or restaurant make a lot of sense. Allowing anyone to smoke a joint in a bar or restaurant would annoy almost everyone, including those smoking the joints.

The East Coast markets have yet another opportunity to lead by redefining social consumption for cannabis. Recently New York’s Office of Cannabis Management approved Cannabis Growers Showcases (CGS) as a stop gap to increase access to safer cannabis products. In a Linkedin post they rightly described this move as meeting consumers “where they are”. I am hoping this is a good sign as it relates to the development of regulations with regard to social consumption lounges as well.

If you or someone you know are building a company that addresses this opportunity please contact us.

Maryland Launching Legalized Cannabis Sales

Maryland joins the 21st century tomorrow and legalizing adult use cannabis for adults 21+. We celebrate each new state that legalizes medical and adult use cannabis, but especially those located on the East Coast.

Maryland represents a significant opportunity given it's shared border with Pennsylvania and Virginia. And while most think of the opportunity of cross-state business, we think of the opportunity being the pressure these border states will feel once Maryland's cannabis industry begins to grow.

A hearty "welcome to the party" Maryland. We've been waiting for you.

Crabcakes, Football ... and cannabis. That's what Maryland does starting July 1.

Pennsylvania and Virginia, you're on the clock.

Go Terps! (both Terrapins and Terpenes in this context).

Trustworthy Advisors for Early Stage Cannabis Companies

Our advisory practice is focused on early stage companies. Our collective experiences punch above their weight class for this group of companies. We offer our services to a wide range of industry sectors from cultivation to software companies and everything in between.

We like to work with companies who value our time just as much as we value theirs. After spending a combined 15 years in the cannabis industry, here are a few things that make us different.

1. You can trust us.

2. We’re effective, respectful communicators.

3. We’re results-driven strategic thinkers.

4. We’re professionals. We don’t put up with nonsense.

5. We care about facts backed by data.

Please contact us at the link the comments section if you'd like to discuss working with us.

Real Ones Only.

No Nonsense.

A Multi-Dimensional Regional Cannabis Market Landscape on the East Coast

Cannabis is personal. Each person experiences cannabis differently just as we experience our lives differently. Cannabis communities form as consumers seek those who have similar or desirable experiences with the plant.

For that reason, we envision a multi-dimensional regional market landscape on the east coast within the next 5 years. These regional and hyper-regional markets will be driven by consumer demands for products that fit their way of life and deliver the value they seek. Brands who are able to align their value they deliver with consumers’ desires at this regional level will establish a foothold in their respective region.

Here are some examples:
- Top Level Regions: NORTHEAST / SOUTHEAST
- Sub Regions: NEW ENGLAND, MID ATLANTIC, CAROLINAS, GEORGIA and FLORIDA
- DMAs: NYC, PHILLY, BOSTON, DC, ATLANTA, MIAMI

Which brands currently have a head start in these regions, sub-regions and DMAs?

MJ Unpacked 2023 Week in New York

It was a great week of meeting entrepreneurs, operators, investors and advocates in the New York cannabis and East Coast cannabis community. The feeling at the events in and around MJ Unpacked was telling.

EVERYONE has their gripe (or multiple gripes). Examples include...

1. Some are frustrated by the slow moving (and sometimes strange moving) progress in New York and New Jersey.
2. Some are frustrated with more Federal failure.
3. Some are frustrated with the absence and poor quality of options to raise capital.

But NO ONE is talking about throwing in the towel.
WELCOME TO NEW YORK.

Speaking of, the highlight of the week was the Welcome to New York Event hosted by the Cannabis Collective where members of the New York cannabis community convened to celebrate the opportunity we have ahead of us. As an executive member, it was a pleasure to see the focus and efforts pay off for Jeffrey Schultz, Andrew Lowitz, Kristina Adduci, Shahbaaz Kara-Virani, Sloane B. and Jes Feuer

If you're interested in joining as a community or executive member, click the link below.

Incremental Change in Insurance Reimbursement for Medical Cannabis

We in the cannabis industry are used to small, incremental steps towards normalization. We believe it’s these small steps that eventually compound and result in lasting changes in mindset. Insurance reimbursement for medical cannabis is one area where we are seeing this incremental change.

While adult use gets the headlines, the medical use case almost always comes first and builds the pathway for adult use. Once a market graduates to adult use, medical use usually drops off as medical patients no longer bother with certifying, seeing a doctor for recommendations and other key elements to a successful medical cannabis program. Why? Because they don’t see the benefit. They can go to an adult use dispensary, get a recommendation from a budtender and buy the same medicine. So even if I am medical patient, why bother? I would argue that adhering to the medical program and working with a physician is a good reason. But fair point, that’s a little weak for the everyday medical user. When a market legalizes adult use, we’ve seen a few ways that medical patients can and should receive priority in order to receive uninterrupted, frictionless access. Such as medical patient only store hours or priority access to specific pain focused products. But what if your medical cannabis was treated like other medicines and all of a sudden you could possibly get reimbursed for that medicine?

Many states are not waiting on federal action and are passing state-level statutes that require or enable insurance carriers to reimburse patients for medical cannabis expenses. Now before everyone with a medical card and “chronic pain” gets excited, most of these state level bills come with caveats to make sure the casual adult use weed smoker is not being reimbursed for medicine. For example, here on the east coast:

1. New York lawmakers approved a bill that would require public health insurance providers in the state to include medical marijuana as a covered prescription drug and authorize private insurers to do the same (so no guarantee for private insurers).

2. A Pennsylvania appeals court ruled that the state’s medical marijuana law does not prohibit insurers from reimbursing injured workers for medical marijuana in cases where the drug is used to treat accepted work injuries.

As we’ve seen medical cannabis can be a viable option for patients with various conditions, we believe as the New York bill states, “Access to medical marijuana should not be limited to those who can pay out of pocket.”

Keeping An Eye On The Carolinas

The Receptive Capital Syndicate is one of only a few investment groups that is focused exclusively on the East Coast cannabis markets. We seek to invest in entrepreneurs with enough grit to launch and grow in these early-stage markets.

Here is what everyone is talking about:
- Massachusetts just surpassed $4B in total sales since adult-use began.
- The tri-state crown jewel of New Jersey, New York and Connecticut are all coming online right now.
- Florida, Pennsylvania and Maryland have working medical markets and are moving towards adult use (Maryland is currently in first place for this race).

But we’re also keeping our eyes on the states that no one is talking about, like North Carolina and South Carolina. North Carolina and South Carolina? Yes, you read that correctly. The Carolinas are getting closer to the right side of history.

Participating in the Regulatory Process in New York’s Cannabis Industry

Yesterday we submitted our first comments to proposed adult use cannabis regulations as an investment firm. Admittedly, being acutely focused on finding outsized investment opportunities in cannabis on the east coast, we have not spent much time in the regulatory framework process. After speaking with trusted advisors who helped us recognize the magnitude of the moment here in our home state of New York, we decided to submit comments to the OCM with respect to proposed adult use regulations. The regulations, as proposed today, create substantial roadblocks to those of us who wish to deploy growth capital for the New York adult use cannabis market. This was the right time for us to participate however there were a few byproducts of the process that we wanted to share.

1. Connecting with others in the space who were reviewing the proposed regulations and opining in parallel sharpened our pencil and gave us a more well rounded understanding of how regulations effect different stakeholders in the industry.

2. As we worked through our recommendations, it was surprising how often it was difficult to come up with a sound recommendation. For example, we could come up with a solution that would fit our investment model, however in working through the ramifications of the solution we would find that it would create a block for different investment models. Creating useful comments that thread the various needles in this industry is not easy.

3. We were under the impression that there were better parties than Receptive Capital to submit comments. So we initially decided to offer our support to others who were organizing comments to be submitted through an organization or group. We thought that this was a sound strategy to make our voices heard as these groups are better connected to the regulators than we are. Almost every group we connected with were happy to have us, but also strongly encouraged us to submit comments independently. “The more the regulators hear from us on the same points, the better.” This was a good learning moment for us as a firm.

A big thank you to Jeffrey Schultz and Bruce Sterman for encouraging, informing and leading.

If you are reading this and you have an opportunity to participate in the regulatory process, we highly recommend it.

Why Aren’t More People Talking About Cannabis As A Potential Alternative To Opioids?

Why aren’t more people in cannabis talking about this?

Cannabis is a potential alternative to opioids because it has been shown to be effective at treating pain. From multiple recently published studies, adult use cannabis markets have a measurable positive impact in the fight against the opioid addiction crisis. And it’s a fight worth fighting. “Opioid overdose deaths in the U.S. between 1999 and 2019, nearly 500,000 Americans died from an opioid related overdose (Centers for Disease Control and Prevention, 2021).”

In a study recently published in Social Science by Samantha Marinello and Lisa M. Powell states with medical cannabis laws (MCL) saw an 8.5% decrease in opioid prescribing relative to states without MCL. These findings are consistent with previous studies published between 2014-2018 which observed reductions in hospitalizations related to opioid dependence, abuse or overdose.

In a separate study recently published in Health Economics by Shyam R. concluded that states that enacted recreational cannabis laws from 2010-2019 led to a reduction in codeine dispensed at retail pharmacies.

Cannabis as a pain management alternative has ZERO overdose risk and far less addiction risk. So what are we waiting for?

Who is developing cannabinoid-based products that specifically target opioid replacement?

Miss Grass Homecoming in New Jersey

Lots of attention on NY and well-deserved. However there is a very exciting story happening in NJ. Miss Grass, a female-founded, female-led brand, originally launched in CA, is taking the state by storm in homecoming fashion for Kate.

After watching the brand from inception in 2018 as a media + marketplace product focused on consumer education, it was a pleasure to walk into a dispensary on the east coast and purchase some Miss Grass pre-rolls. This is a brand anchored in consumer education on display. Thoughtful, unique design and messaging (recently refreshed). Visually appealing and inviting. The box of matches is a fitting touch. The promise of enhancing your experience or “times” is certainly delivered. NJ being the 5th state the brand has entered successfully, we feel confident saying that while most cannabis brands are talking about it, Miss Grass is actually doing it.

Cheers to the Miss Grass team for actually doing it.

FWIW, the Ascend store in Fort Lee has a pretty thoughtful floor design for consumer education purposes with many approachable displays. I knew exactly what I wanted because I went there specifically to get Miss Grass pre-rolls so I pre-ordered and the pick up process was as simple as it should be. First time using Dispense as well. Sign up was easy. Elegant and clean UX.